About

Dr. Manish R Biyani have combine expertise directing multiple initiatives simultaneously using strong time management and prioritization skills. Equipped with B pharm, M pharm (India) & PhD in Organic Chemistry at ๐—›๐—ฒ๐—ฟ๐—ถ๐—ผ๐˜-๐—ช๐—ฎ๐˜๐˜ ๐—จ๐—ป๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ถ๐˜๐˜†, ๐—จ๐—ž alongside strong educational background in higher management. Accomplished 15 years of experience leading complex drug development and pharmaceutical manufacturing projects from concept development through to clinical trials and drug commercialization. Results-driven Pharma Leader with proven success fostering strong collaborative relationships with regulators, key stakeholders, and high-value clients in India, US, UK, Europe. Demonstrated ability to collaborate with stakeholders across R&D groups, quality, manufacturing, regulatory, clinical development, and SCM. Articulate communicator with credible history of cultivating positive partnerships with interdepartmental teams, management peers, and key clientele to realize strategic business goals.

Demonstrated capabilities in IPR, Corporate strategy, Project management, SCM, Technology evaluation, Digital transformation, Business intelligence (Data Analytics & Market research). He enables organization with project governance framework, multi-country patent strategy, business insights, Aligning business with Risk, Strategy & P & L

โ–บCommitted Project Management Professional with demonstrated expertise establishing project governance framework to plan, monitor, and control project deliverables, to identify and mitigate risks, and to complete projects on-time and within budget.

โ–บTrusted resource to executive leadership team in relation to multi-country patent strategy development and patent filing, being granted over ๐ญ๐ž๐ง ๐—ฝ๐—ฎ๐˜๐—ฒ๐—ป๐˜๐˜€ in drug discovery and development.

โ–บCommitted Professional leveraging key market analysis skills to identify $ ๐Ÿฎ๐—  potential savings by competitive landscape

Strong background working in multiple start-ups & ability of exploring novel concepts in pharmaceutical, nutraceutical & food & beverage industries. As my professional career continues to evolve, I remain steadfast in my belief that collaboration is the key to business & thus committed to building positive relationships with interdepartmental teams, senior management, & key clientele. It is through these bonds that deals are closed and organizational goals are achieved.

Major areas of Research have been on Preclinical & clinical in drug-induced liver injury, anti-oxidant studies, Toxicological studies, CNS, immunology, neurobiology, addiction, DNA damage, oligonucleotide research, inflammation, & gout. Organic Chemistry experience in API process development, and multi-step NCE synthesis in areas such as nucleic acid synthesis, carbohydrates, macrolides (Antibiotics) and heterocyclic compounds & chiral separation (chiral auxiliaries & resolving agents).

Research interests

Found 
Found 
Found 
Total publications
3
Total citations
34
Citations per publication
11.33
Average publications per year
1
Average coauthors
4.67
Publications years
2016-2018 (3 years)
h-index
2
i10-index
1
m-index
0.67
o-index
7
g-index
3
w-index
1
Metrics description
h-index
A scientist has an h-index if h of his N publications are cited at least h times each, while the remaining (N - h) publications are cited no more than h times each.
i10-index
The number of the author's publications that received at least 10 links each.
m-index
The researcher's m-index is numerically equal to the ratio of his h-index to the number of years that have passed since the first publication.
o-index
The geometric mean of the h-index and the number of citations of the most cited article of the scientist.
g-index
For a given set of articles, sorted in descending order of the number of citations that these articles received, the g-index is the largest number such that the g most cited articles received (in total) at least g2 citations.
w-index
If w articles of a researcher have at least 10w citations each and other publications are less than 10(w+1) citations, then the researcher's w-index is equal to w.

Top-100

Fields of science

1
Biochemistry, 1, 33.33%
Biochemistry
1 publication, 33.33%
Medicine (miscellaneous), 1, 33.33%
Medicine (miscellaneous)
1 publication, 33.33%
General Medicine, 1, 33.33%
General Medicine
1 publication, 33.33%
Pharmacology, 1, 33.33%
Pharmacology
1 publication, 33.33%
Food Science, 1, 33.33%
Food Science
1 publication, 33.33%
Neurology, 1, 33.33%
Neurology
1 publication, 33.33%
Nutrition and Dietetics, 1, 33.33%
Nutrition and Dietetics
1 publication, 33.33%
Toxicology, 1, 33.33%
Toxicology
1 publication, 33.33%
Behavioral Neuroscience, 1, 33.33%
Behavioral Neuroscience
1 publication, 33.33%
Health (social science), 1, 33.33%
Health (social science)
1 publication, 33.33%
1

Journals

1
Alcohol
1 publication, 33.33%
Journal of Functional Foods
1 publication, 33.33%
Phytotherapy Research
1 publication, 33.33%
1

Citing journals

1
2
3
Journal not defined, 3, 8.82%
Journal not defined
3 citations, 8.82%
Phytotherapy Research
3 citations, 8.82%
Dermatologic Therapy
2 citations, 5.88%
Nutrients
2 citations, 5.88%
Alcohol
2 citations, 5.88%
Drugs and Drug Candidates
2 citations, 5.88%
Colloids and Surfaces B: Biointerfaces
1 citation, 2.94%
PeerJ
1 citation, 2.94%
Pharmacological Research
1 citation, 2.94%
Phytomedicine
1 citation, 2.94%
Medicinal Chemistry Research
1 citation, 2.94%
JAOCS, Journal of the American Oil Chemists' Society
1 citation, 2.94%
Annals of Medicine
1 citation, 2.94%
Experimental Eye Research
1 citation, 2.94%
Journal of Functional Foods
1 citation, 2.94%
Food and Function
1 citation, 2.94%
Journal of Ethnopharmacology
1 citation, 2.94%
Antioxidants
1 citation, 2.94%
Metabolites
1 citation, 2.94%
Current Drug Metabolism
1 citation, 2.94%
Food Chemistry
1 citation, 2.94%
Drug and Chemical Toxicology
1 citation, 2.94%
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
1 citation, 2.94%
Egyptian Liver Journal
1 citation, 2.94%
American Journal of Plant Sciences
1 citation, 2.94%
Experimental and Clinical Gastroenterology
1 citation, 2.94%
1
2
3

Publishers

1
2
Elsevier
2 publications, 66.67%
Wiley
1 publication, 33.33%
1
2

Organizations from articles

1
2
3
Creighton University
3 publications, 100%
Medical College and Hospital, Kolkata
1 publication, 33.33%
1
2
3

Countries from articles

1
2
3
USA, 3, 100%
USA
3 publications, 100%
India, 3, 100%
India
3 publications, 100%
1
2
3

Citing organizations

1
2
3
4
5
6
7
8
Organization not defined, 8, 23.53%
Organization not defined
8 citations, 23.53%
King Saud University
2 citations, 5.88%
Mashhad University of Medical Sciences
2 citations, 5.88%
Qingdao University of Science and Technology
2 citations, 5.88%
Creighton University
2 citations, 5.88%
Sechenov First Moscow State Medical University
1 citation, 2.94%
Saint Petersburg State University
1 citation, 2.94%
Saint-Petersburg State Chemical and Pharmaceutical University
1 citation, 2.94%
King Abdullah International Medical Research Center
1 citation, 2.94%
King Saud bin Abdulaziz University for Health Sciences
1 citation, 2.94%
University of Kashmir
1 citation, 2.94%
Zabol University of Medical Sciences
1 citation, 2.94%
Tongji University
1 citation, 2.94%
Medical College and Hospital, Kolkata
1 citation, 2.94%
University Putra Malaysia
1 citation, 2.94%
Beijing University of Chinese Medicine
1 citation, 2.94%
Capital Medical University
1 citation, 2.94%
Tianjin University of Traditional Chinese Medicine
1 citation, 2.94%
University of Padua
1 citation, 2.94%
Taipei Medical University
1 citation, 2.94%
Taipei Medical University Hospital
1 citation, 2.94%
China Medical University (Taiwan)
1 citation, 2.94%
University of Trento
1 citation, 2.94%
University of Ferrara
1 citation, 2.94%
Kyungpook National University
1 citation, 2.94%
Dongguk University
1 citation, 2.94%
Chonnam National University Hospital
1 citation, 2.94%
Yeungnam University
1 citation, 2.94%
Daegu Haany University
1 citation, 2.94%
Shaoxing University
1 citation, 2.94%
Shandong University
1 citation, 2.94%
Innsbruck Medical University
1 citation, 2.94%
Virginia Commonwealth University
1 citation, 2.94%
Zagazig University
1 citation, 2.94%
Ain Shams University
1 citation, 2.94%
University of Manitoba
1 citation, 2.94%
University of Jaรฉn
1 citation, 2.94%
University of Carthage
1 citation, 2.94%
Pokhara University
1 citation, 2.94%
Universidade Federal do Cearรก
1 citation, 2.94%
1
2
3
4
5
6
7
8

Citing countries

2
4
6
8
10
China, 10, 29.41%
China
10 citations, 29.41%
USA, 5, 14.71%
USA
5 citations, 14.71%
India, 5, 14.71%
India
5 citations, 14.71%
Country not defined, 4, 11.76%
Country not defined
4 citations, 11.76%
Egypt, 2, 5.88%
Egypt
2 citations, 5.88%
Iran, 2, 5.88%
Iran
2 citations, 5.88%
Italy, 2, 5.88%
Italy
2 citations, 5.88%
Republic of Korea, 2, 5.88%
Republic of Korea
2 citations, 5.88%
Saudi Arabia, 2, 5.88%
Saudi Arabia
2 citations, 5.88%
Russia, 1, 2.94%
Russia
1 citation, 2.94%
Austria, 1, 2.94%
Austria
1 citation, 2.94%
Brazil, 1, 2.94%
Brazil
1 citation, 2.94%
United Kingdom, 1, 2.94%
United Kingdom
1 citation, 2.94%
Spain, 1, 2.94%
Spain
1 citation, 2.94%
Canada, 1, 2.94%
Canada
1 citation, 2.94%
Malaysia, 1, 2.94%
Malaysia
1 citation, 2.94%
Nepal, 1, 2.94%
Nepal
1 citation, 2.94%
UAE, 1, 2.94%
UAE
1 citation, 2.94%
Tunisia, 1, 2.94%
Tunisia
1 citation, 2.94%
2
4
6
8
10
  • We do not take into account publications without a DOI.
  • Statistics recalculated daily.